Category: Healthcare

Global Robotic Surgery Market growing at a CAGR of 10.5% during 2018-2025-GMI Research

Global Robotic Surgery Market growing at a CAGR of 10.5% during 2018-2025-GMI Research

The Global Robotic Surgery Market reached USD 4,061.9 million in 2017, and is expected to touch USD 8,987.4 million by 2025, growing at a CAGR of 10.5% during 2018–2025. The key factors boosting growth of the market are the increasing number of patients suffering from chronic diseases, increasing need for quality patient care, efficiency in solutions.

Request Sample Pages : https://tinyurl.com/y492mbyo

Furthermore, advancements in Robotic and advanced surgical procedures with the use of Surgical Robots across the globe have led to burgeoning market growth of Robotic Surgery Market.

General Surgery segment is expected to dominate the Robotic Surgery Market during the forecast period in terms of revenues. However, the highest growth rate is expected to be witnessed by the Others segment during the forecast period owing to increasing demand for robotic applications in various types of surgeries.

Technological advancement in Surgical industry and increasing awareness about the robotic surgeries are likely to drive the growth of Robotic Surgery Market in the near future. Accessories and instruments to dominate the market in terms of revenue share in the application segment in 2017.

The companies are focussing on mergers, new product launches and implementation of healthcare services and investing in research and development to maintain their leadership in the competitive Robotic Surgery Market.”GMI Research

Based on geography, North America held the largest revenue share in 2017 because of high technological advancement in the hospitals, awareness among the public regarding the robotic surgical procedures and the advantages of this surgery over the traditional ones. ROW is the fastest growing region and the market is expected to grow at a CAGR of 12.1% during the forecast period.

Request for Customization : https://tinyurl.com/y2qttwb8

Key takeaways/key essentials:

  • Mazor Robotics, TransEnterix, Accuray together holds more than half of the market share in 2017.
  • The General Surgery Segment is anticipated to grow at the highest rate during the forecast period from 2018 to 2025.
  • The services segment is the emerging segment in the Surgical field due to requirements to get the devices serviced more frequently to improve the quality surgery.
  • In 2017, North America region captured maximum revenue share in Global Robotic Surgery Market.

Some of the key players operating in Global Robotic Surgery Market include Mazor Robotics, TransEnterix, Accuray, Medtech SAS, Smith & Nephew, Renishaw, Corindus Vascular Robotics, among others.

The Global Robotic Surgery Market has been segmented on the basis of application type, the market comprises of Gynaecology, General Surgery, Urology and Others. The component type includes Accessories and instruments, Services.

The research report “Global Robotic Surgery Market” provides an in-depth analysis of the Robotic Surgery Market, globally, based on Components, Applications and major geographies for the forecast period from 2018 to 2025. The report highlights the major market drivers propelling the growth as well as challenges faced by the market participants. The research report provides market size and forecast for Robotic Surgery Market. The report also analyses the competitive landscape, major players and their strategies in 2018. The competitive landscape section of the report captures and highlights the recent developments in the market.

For more details, browse the Table of Contents: https://www.gmiresearch.com/report/global-robotic-surgery-market/

Contact Sarah Nash

Tel: +353 1 536 3035

U.S Office +1 860 881 2270

Europe Office +353 1 442 8820

Email: enquiry@gmiresearch.com

 

Rising adoption of minimally invasive treatments for chronic disorders across the globe will propel the growth of injectable nanomedicines market during the forecast period

Rising adoption of minimally invasive treatments for chronic disorders across the globe will propel the growth of injectable nanomedicines market during the forecast period

The global injectable nanomedicines market touched USD 479.6 million in 2017, and is expected to reach USD 833.9 million by 2025, growing at a CAGR of 7.3% during 2018–2025.


Source: GMI Research

Major Factors driving the market growth are:
· Growing incidence of chronic diseases like cancer, cardiovascular diseases, neurological disorders
· Increasing research & development activities and clinical trials
· Rising demand and adoption of minimally invasive treatments
· Rising government and private funding
· Increasing geriatric population

Growing demand for minimal invasive treatments is driving the Injectable Nanomedicines market. Introduction of innovative and advanced nanotechnology and nanomedicines, especially in the emerging markets with the help of government and private funding would spur the growth of market for the injectable nanomedicines during the forecast period.

Request Sample @ https://tinyurl.com/y2anq5dq

A paradigm shifts from traditional therapeutics to novel therapeutics using nanomedicines is propelling the overall market as nanomedicines have higher payload capacity, prolonged blood circulation times, reduced toxicity and improved anti-tumour efficacy. Moreover, the application of injectable nanomedicines for some widespread chronic diseases like migraine and depression is also aiding market growth. The use of injectable nanomedicines are found to be efficient, lasting and easy treatment of many chronic cardiovascular and neurological disorders.

Growing incidence rate due to aging demographic patterns and the extension of health insurance coverage in a developing region will support the market growth. Advancements in cancer drug delivery and personalized cancer treatments, effective and safe treatment of medically refractory movement disorders and the need for fast and efficient cardiovascular systems will primarily drive the global injectable nanomedicine market.

“The rising pool of patients of chronic diseases and the need for a fast, efficient and long-lasting treatment with minimal invasion procedures will drive the injectable nanomedicines market.”
—-GMI Research

Based on geography, North America held the largest market share in 2017 due to the significantly high rate of incidence of cancer as well as cardiovascular diseases in the region. Currently, the region has a growing demand for rapid research & development of novel nanomedicine in order to address unmet medical needs. Furthermore, favourable reimbursement policies and increasingly growing partnerships between leading enterprises and nanomedicine start-ups is also expected to create growth opportunities. Europe is the second largest market in 2017 and is promising market due to developed healthcare system and rising adoption of nanomedicine in oncology sector. Asia-Pacific is expected to show promising growth in global injectable nanomedicines during 2018-2025 due to the increasing government and private funding for health care infrastructure along with the rising incidence of neurological disorders. Moreover, increasing adoption of nanomedicine for the treatment of cancer, diabetes, cardiovascular diseases and some infectious disease in the Asia-Pacific region would also contribute significantly to the market growth for injectable nanomedicines in the region.

Request for Customization : https://tinyurl.com/y342k6as

Based on geography, North America held the largest market share in 2017 due to the significantly high rate of incidence of cancer as well as cardiovascular diseases in the region. Currently, the region has a growing demand for rapid research & development of novel nanomedicine in order to address unmet medical needs. Furthermore, favourable reimbursement policies and increasingly growing partnerships between leading enterprises and nanomedicine start-ups is also expected to create growth opportunities. Europe is the second largest market in 2017 and is promising market due to developed healthcare system and rising adoption of nanomedicine in oncology sector. Asia-Pacific is expected to show promising growth in global injectable nanomedicines during 2018-2025 due to the increasing government and private funding for health care infrastructure along with the rising incidence of neurological disorders. Moreover, increasing adoption of nanomedicine for the treatment of cancer, diabetes, cardiovascular diseases and some infectious disease in the Asia-Pacific region would also contribute significantly to the market growth for injectable nanomedicines in the region.

Key takeaways/key essentials:
· In 2017, the cancer treatment held the major share for the injectable nanomedicines market followed by the cardiovascular diseases segment.
· High demand and adoption rate for minimally invasive treatments in the recent past.
· Extended research and development activities are taking place using the injectable nanomedicines regarding the concept of targeted drug delivery system.

Some of the key players operating in the global market for injectable nanomedicines include Merck & Co., Inc., Lupin, Pacira Pharmaceuticals Inc., Celgene Pharmaceutical Co. Ltd., Amgen, Inc., Janssen Biotech Inc., Pfizer Inc., Hoffmann-La Roche Ltd., Teva Pharmaceutical Industries Ltd., Bausch & Lomb Inc. among others.

The global injectable nanomedicines market has been segmented based on product type, indication type and key geographies. Based on the product type, global injectable nanomedicines market has been segmented into liposomes, micelles, nanocrystals and others. Based on indication type, the market has been segmented into cancers, central nervous system diseases, cardiovascular diseases, inflammatory diseases and others.

The research report “global injectable nanomedicines market” provides in-depth analysis of injectable nanomedicines market, globally, based on product type, indication and major geographies for the forecast period from 2018 to 2025. The report highlights the major market drivers fuelling the growth as well as challenges faced by the market participants. The research report provides market size and forecast for injectable nanomedicines market. The report also analyses the competitive landscape, major players and their strategies in 2018. The competitive landscape section of the report captures and highlights the recent developments in the market.

For more details, browse the Table of Contents: https://www.gmiresearch.com/report/global-injectable-nanomedicines-market-by-product/

Contact Sarah Nash
Tel: +353 1 536 3035
U.S Office +1 860 881 2270
Europe Office +353 1 442 8820
Email: enquiry@gmiresearch.com

Global Nucleic Acid Testing Market Opportunities & Forecast 2018-2025-GMI Research

Global Nucleic Acid Testing Market Opportunities & Forecast 2018-2025-GMI Research

Global Nucleic Acid Testing Market by Product Type (Nucleic Acid test Kits (Transcription-mediated amplification (TMA), Polymerase chain reaction (PCR), Ligase chain reaction (LCR), Whole genome sequencing) and Consumables), by Indication, by End User and by Geography – Opportunities & Forecast 2018-2025

Nucleic Acid Testing market has huge potential to grab the maximum revenue share during the forecast period. The introduction of this nucleic acid testing technology has revolutionized the field of clinical molecular diagnosis and forensic science. The nucleic acid testing market is likely to witness lucrative growth during forecast period owing to higher growth rate of molecular diagnosis, treatment and research activities. Moreover, high adaption of nucleic acid testing in chronic disease diagnosis and forensic testing will creates huge opportunity during the forecast period.

Download Sample Brochure : https://www.gmiresearch.com/sample-research-report.php?rid=124

Rising incidence of infection diseases and growing cancer patients worldwide are the major factor that increases demand of diagnosis. Molecular Diagnosis industry adopted nucleic acid testing techniques for fast, reliable and accurate outcomes which boost the market during the forecast period. In addition, established healthcare infrastructure and improving reimbursement policy in developed economies are also driving force to the nucleic acid testing market growth. Increase in research & development activities across the globe especially in Asia pacific region creates huge potential revenue during the forecast period.

Expanding need for nucleic acid testing from blood transfusion centers and blood donation centers will significantly anchor the whole blood transfusion processes, which is foreseen to reinforce the development of the worldwide nucleic acid testing market 

Various notable players operating the nucleic acid testing market include Agilent Technologies, Danaher Corporation, Abbott Laboratories Inc., Becton, Dickinson and Company, Bio-Rad Laboratories Inc., F. Hoffmann-La Roche Ltd., Illumina Inc., Thermo Fisher Scientific Inc., Qiagen, and Merck KGaA, among others.

The global nucleic acid testing market has been segmented on the basis of product type, indication, end user and key geographies. Based on product type, the market comprises of nucleic acid test kits and consumables. Based on indication, the market is segmented into Infectious diseases, Cancer, Forensic Testing and Others

This research report on nucleic acid testing market provides in-depth analysis of the global nucleic acid testing market based on product type, indication, end user and major geographies for the forecast period from 2018 to 2025. The report highlights the major market drivers propelling the growth as well as challenges faced by market participants. The research report provides market size and forecast for nucleic acid testing market. The report also analyses the competitive landscape, major players and their strategies in 2018. The competitive landscape section of the report captures and highlights the recent development in the market.

Key questions answered in this research report:
1-    At what pace is nucleic acid testing market growing? What will be growth trend in future?
2-    What are the key drivers and restraints in the current market? What will be the impact of drivers and restraints in the future?
3-    What are the regional revenue and forecast breakdowns? Which are the major regional revenue pockets for growth in the nucleic acid testing market?
4-    What are the various application areas and how they are poised to grow?

The global nucleic acid testing market is segmented on the basis of product type, indication, end user and geography:

Global Nucleic Acid Testing Market by Product Type

·  Nucleic Acid test Kits

o    Transcription-mediated amplification (TMA)

o    Polymerase chain reaction (PCR)

o    Ligase chain reaction (LCR)

o    Whole genome sequencing

·         Consumables

 

Global Nucleic Acid Testing Market by Indication

·         Infectious diseases

·         Cancer

·         Forensic Testing

·         Others

Global Nucleic Acid Testing Market by End User

·         Hospitals

·         Pathology laboratories

·         Research Institutes

·         Clinics

Global Nucleic Acid Testing Market by Geography

·         North America

·         Asia-Pacific

·         Europe

·         Rest of World 

Global Nucleic Acid Testing Market Competitive Landscape

·         Major Players and their Key Strategies 

·         New product launches

·         Mergers and acquisitions

·         Collaborations, partnerships, agreements and joint venture

BUY Premuim Report : https://www.gmiresearch.com/buy-research-report.php?rid=124&licence=singaluser

Table of Contents (TOC)

1. Executive Summary 

2. Introduction
        2.1. Study Objectives
        2.2. Market Definition
                2.2.1.  Market Covered
                2.2.2. Geographical Coverage
                2.2.3. Study Years & Currency
        2.3. Market Stakeholders
        2.4. Key Questions this Study will Answer
        2.5. GMI Research’s Approach & Methodology
3. Global Nucleic Acid Testing Market – Overview
        3.1. Introduction         `
        3.2. Market Segmentation
        3.3. Value Chain Analysis
        3.4. Drivers
        3.5. Restraints
        3.6. Trends
4. Global Nucleic Acid Testing Market Revenue Forecast till 2025     
 
5. Global Nucleic Acid Testing Market by Product Type Revenue Forecast till 2025 
        5.1. Nucleic Acid test Kits
                5.1.1. Transcription-mediated amplification (TMA)
                5.1.2. Polymerase chain reaction (PCR)
                5.1.3. Ligase chain reaction (LCR)
                5.1.4. Whole genome sequencing
         5.2. Consumables
6. Global Nucleic Acid Testing Market by Indication Revenue Forecast till 2025 
        6.1. Infectious diseases
        6.2. Cancer
        6.3. Forensic Testing
        6.4. Others
7. Global Nucleic Acid Testing Market by End User Revenue Forecast till 2025
        7.1. Hospitals
        7.2. Pathology laboratories
        7.3. Research Institutes
        7.4. Clinics
8. Global Nucleic Acid Testing Market by Geography Revenue Forecast till 2025
        8.1. North America Nucleic Acid Testing Market Revenue Forecast till 2025
                8.1.1. North America Nucleic Acid Testing Market by Product Type (Option 1: 25% customization)
                                8.1.1.1. Nucleic Acid test Kits
                                                8.1.1.1.1. Transcription-mediated amplification (TMA)
                                                8.1.1.1.2. Polymerase chain reaction (PCR)
                                                8.1.1.1.3. Ligase chain reaction (LCR)
                                                8.1.1.1.4. Whole genome sequencing
                                8.1.1.2. Consumables
                8.1.2. North America Nucleic Acid Testing Market by Indication
                                8.1.2.1. Infectious diseases
                                8.1.2.2. Cancer
                                8.1.2.3. Forensic Testing
                                8.1.2.4. Others
                8.1.3. North America Nucleic Acid Testing Market by End User
                                8.1.3.1. Hospitals
                                8.1.3.2. Pathology laboratories
                                8.1.3.3. Research Institutes
                                8.1.3.4. Clinics
        8.2. Europe Nucleic Acid Testing Market Revenue Forecast till 2025
                8.2.1. Europe Nucleic Acid Testing Market by Product Type (Option 2: 25% customization)
                                8.2.1.1. Nucleic Acid test Kits
                                                8.2.1.1.1. Transcription-mediated amplification (TMA)
                                                8.2.1.1.2. Polymerase chain reaction (PCR)
                                                8.2.1.1.3. Ligase chain reaction (LCR)
                                                8.2.1.1.4. Whole genome sequencing
                                8.2.1.2. Consumables
                8.2.2. Europe Nucleic Acid Testing Market by Indication
                                8.2.2.1. Infectious diseases
                                8.2.2.2. Cancer
                                8.2.2.3. Forensic Testing
                                8.2.2.4. Others
                8.2.3. Europe Nucleic Acid Testing Market by End User
                                8.2.3.1. Hospitals
                                8.2.3.2. Pathology laboratories
                                8.2.3.3. Research Institutes
                                8.2.3.4. Clinics
        8.3. Asia-Pacific Nucleic Acid Testing Market Revenue Forecast till 2025
                8.3.1. Asia-Pacific Nucleic Acid Testing Market by Product Type (Option 3: 25% customization)
                                8.3.1.1. Nucleic Acid test Kits
                                                8.3.1.1.1. Transcription-mediated amplification (TMA)
                                                8.3.1.1.2. Polymerase chain reaction (PCR)
                                                8.3.1.1.3. Ligase chain reaction (LCR)
                                                8.3.1.1.4. Whole genome sequencing
                                8.3.1.2. Consumables
                8.3.2. Asia-Pacific Nucleic Acid Testing Market by Indication
                                8.3.2.1. Infectious diseases
                                8.3.2.2. Cancer
                                8.3.2.3. Forensic Testing
                                8.3.2.4. Others
                8.3.3. Asia-Pacific Nucleic Acid Testing Market by End User
                                8.3.3.1. Hospitals
                                8.3.3.2. Pathology laboratories
                                8.3.3.3. Research Institutes
                                8.3.3.4. Clinics
        8.4. Rest of the World Nucleic Acid Testing Market Revenue Forecast till 2025
                8.4.1. Rest of the World Nucleic Acid Testing Market by Product Type (Option 4: 25%                                                    customization)
                                8.4.1.1. Nucleic Acid test Kits
                                                8.4.1.1.1. Transcription-mediated amplification (TMA)
                                                8.4.1.1.2. Polymerase chain reaction (PCR)
                                                8.4.1.1.3. Ligase chain reaction (LCR)
                                                8.4.1.1.4. Whole genome sequencing
                                8.4.1.2. Consumables
                8.4.2. Rest of the World Nucleic Acid Testing Market by Indication
                                8.4.2.1. Infectious diseases
                                8.4.2.2. Cancer
                                8.4.2.3. Forensic Testing
                                8.4.2.4. Others
                8.4.3. Rest of the World Nucleic Acid Testing Market by End User
                                8.4.3.1. Hospitals
                                8.4.3.2. Pathology laboratories
                                8.4.3.3. Research Institutes
                                8.4.3.4. Clinics
9. Competitive Landscape
        9.1. Industry Attractiveness
        9.2. Porter 5 Analysis
        9.3. Major players and their key strategies
        9.4. Company Share Analysis
10. Company Profiles (Option 5: 25% Customization – Profiles of 5 Additional Companies of your                  Choice)
        10.1. Agilent Technologies
                          10.1.1.1. Company Overview
                           10.1.1.2. Financials
                           10.1.1.3. Recent Developments
        10.2. Danaher Corporation
                           10.2.1.1. Company Overview
                          10.2.1.2. Financials
                          10.2.1.3. Recent Developments
        10.3. Abbott Laboratories, Inc.
                          10.3.1.1. Company Overview
                          10.3.1.2. Financials
                          10.3.1.3. Recent Developments
        10.4. Becton, Dickinson and Company
                          10.4.1.1. Company Overview
                          10.4.1.2. Financials
                          10.4.1.3. Recent Developments
        10.5. Bio-Rad Laboratories Inc.
                          10.5.1.1. Company Overview
                          10.5.1.2. Financials
                          10.5.1.3. Recent Developments
        10.6. F. Hoffmann-La Roche Ltd.
                          10.6.1.1. Company Overview
                          10.6.1.2. Financials
                          10.6.1.3. Recent Developments
        10.7. Illumina, Inc.
                          10.7.1.1. Company Overview
                          10.7.1.2. Financials
                          10.7.1.3. Recent Developments
        10.8. Thermo Fisher Scientific Inc.
                          10.8.1.1. Company Overview
                          10.8.1.2. Financials
                          10.8.1.3. Recent Developments
        10.9. Qiagen
                          10.9.1.1. Company Overview
                          10.9.1.2. Financials
                          10.9.1.3. Recent Developments
        10.10. Merck KGaA,
                          10.10.1.1. Company Overview
                          10.10.1.2. Financials
                          10.10.1.3. Recent Developments
11. About GMI Research
About US
GMI Research is a market research and consulting firm which provides research-based solutions to business executives and investment professionals so that they can make right business & investment decisions faster based on real facts. We help business leaders through independent fact-based insight, ensuring their business achieve success by beating the competition.

Contact – Sarah Nash

Level 1, The Chase Carmanhall Road,
Sandyford Industrial Estate,
Dublin D18 Y3X2, Ireland

U.S Office +1 860 881 2270
Europe Office +353 1 442 8820

Email: sales@gmiresearch.com

Global Infant Nutritional Premix Market Opportunities & Forecast (2018-2025)-GMI Research

Global Infant Nutritional Premix Market Opportunities & Forecast (2018-2025)-GMI Research

Global Infant Nutritional Premix Market by Product Form (Powered and Liquid), by Ingredients (Vitamins, Minerals, Amino Acids, Nucleotides among others), by Functionality ( Bone Health, Immunity, Digestion, Vision health, Brain Health and Memory and Others), by Distribution Channel ( Pharmacy, Specialty Outlets, Supermarkets, Online Stores and Others) and by Geography – Opportunities & Forecast, 2018-2025

Infant food products are intended to provide nutrition to infants. Infant Nutritional Premix is a combination of essential vitamins, minerals, amino acids, nucleotides and other functional ingredients that are used in infant products, which facilitate infant nutrition. Therefore, in order to stimulate postnatal growth and to reduce infant mortality and morbidity rate, they need to have enough vitamins and minerals.

Download Sample Brochure : https://tinyurl.com/y9qokgx2

Major factors driving the growth of infant nutritional premixes is the convenience it provides for working men and women, who have ready to eat food for their infants, which can be prepared in lesser time and comes with an optimum mix of all the required nutrients required for their healthy growth. Moreover, for babies who are not being breastfed, these infant formulas are combined with ingredients like vitamin D, iron, DHA (docosahexaenoic acid) and ARA (arachidonic acid). With innovation in packaging and increasing awareness as regards the advantages of consuming fortified infant nutrition products, and unique formulations, the global infant nutrition premixes market is expected to grow exponentially in the coming years.

Various notable players operating in the market, include Watson-Inc., Lycored Limited, Barentz International B.V, BASF SE, Fenchem biotek Ltd, Nestle S.A, Royal Friesland Campina, Jubilant Life Sciences Limited, Hexagon Nutritional Pvt. Ltd. among others. The major players are focussing on innovation in formulas and expansion; for instance, Vitablend (part of Barentz group) opened a production plant for specialized Infant and Clinical Food in Singapore.

The Global Infant Nutritional Premixes market has been segmented on the basis of product form, ingredients, functionality, distribution channel and key geographies; based on product form, the market is segmented into powers and liquids; based on ingredients, the market is categorized into Vitamins, Minerals, Amino Acids, Nucleotides among others; based on functionality, the market is segmented into Bone Health, Immunity, Digestion, Vision health, Brain Health and Memory among others; based on the distribution channel, it is divided into Pharmacy, Specialty Outlets, Supermarkets, Online Stores among others.

This research report on ‘Global infant nutritional premixes market’ provides an in-depth analysis of global infant nutritional premix market based on product form, ingredients, functionality, distribution channels and major geographies for the forecast period from 2018 to 2025. The report also highlights the major market drivers that propel growth, and also indicates the challenges faced by market participants. Moreover, the research report provides market size and forecast for the global infant nutritional premix market, analysing the competitive landscape, major players and their strategies in 2018. The competitive landscape section of the report captures and highlights the recent developments in the market.

Buy Now : https://tinyurl.com/y9qokgx2

Key questions answered in this research report:
1-    At what pace is infant nutritional premixes market growing? What will be the growth trend in the future?
2-    What are the key drivers and restraints in the current market? What will be the impact of drivers and restraints in the future?
3-    What are the regional revenue and forecast breakdowns? Which are the major regional revenue pockets for growth in the infant nutritional premix market?
4-    What are the various application areas, and how they are poised to grow?

Market Segmentation
By Product Form

•    Powered Premixes
•    Liquid Premixes
By Ingredients
•    Vitamins
•    Minerals
•    Amino Acids
•    Nucleotides
•    Others
By Functionality 
•    Bone Health
•    Immunity
•    Digestion
•    Vision Health
•    Brain Health and Memory
By Distribution Channel
•    Pharmacy
•    Specialty Outlets
•    Supermarkets
•    Online Stores
•    Others
By Geography
•    North America 
As a part of the customization
o    By Product Form
o    By Ingredients
o    By Functionality
o    By Distribution Channel
o    US
o    Canada
o    Mexico
•    Europe
As a part of the customization
o    By Product Form
o    By Ingredients
o    By Functionality
o    By Distribution Channel
o    UK
o    Germany
o    Spain
o    Rest of Europe
•    Asia-Pacific
As a part of the customization
o    By Product Form
o    By Ingredients
o    By Functionality
o    By Distribution Channel
o    China
o    Australia
o    India
o    Rest of APAC
•    ROW
As a part of the customization
o    By Product Form
o    By Ingredients
o    By Functionality
o    By Distribution Channel
o    Brazil
o    South Africa
o    GCC countries
o    Rest of world (remaining countries of the LAMEA region)

Leading market players
•    Watson-Inc.
•    Lycored Limited
•    Beingmate Baby & Child Food Co. Ltd
•    Barentz International B.V
•    BASF SE
•    Fenchem biotek Ltd
•    Nestle S.A
•    Royal Friesland Campina
•    Jubilant Life Sciences Limited
•    Hexagon Nutritional Pvt. Ltd.

*Other prominent players in the market which can be profiled as a part of customization:
•    ADM Company
•    Abbott Nutrition Manufacturing Inc.
•    The Kraft Heinz Company
•    Pfizer Inc.
•    FrieslandCampinaRapid Shape DWS (Italy)

For more details, browse the Table of Contents : https://www.gmiresearch.com/report/global-infant-nutritional-premix-market.html

Related Report:

Global Pet Food Market, By Pet Type (Dogs, Cats, and Others), By Point of Sale (Online, Hypermarkets, and Specialized Retail Stores), By Food Type (Dry, wet and Treats), By Food Category (Meat, Cereals, Vegetables and Fruits and Fats and Additives), and Geography – Opportunities & Forecast, 2018-2025

About US

GMI Research is a market research and consulting firm which provides research-based solutions to business executives and investment professionals so that they can make right business & investment decisions faster based on real facts. We help business leaders through independent fact-based insight, ensuring their business achieve success by beating the competition.

GMI Research leverages its industry expertise and experience to identify the industry trends, big opportunities and potential growth areas across industries. Our Syndicated reports provide actionable insights and covers industry trends, market drivers & restraints, macroeconomics factors, market estimates & forecasts, competitive landscape etc. which helps our clients to strengthen its market position by deploying specific strategies and actions that will lead to higher growth. 

Our Customized Research (Market Intelligence and Competitive Intelligence) Offerings

Our clients rely on us for the range of our services to give them the intelligence they need to act decisively. GMI Research offers in-depth market and competitive intelligence solutions by leveraging its industry knowledge and experience to provide accurate insights with a complete picture of the market and competition. To know more about our product offering click on the below link:

https://www.gmiresearch.com/productservices/marketcompetitiveintelligence.html

Our Company Profile Solution

Company Profiles provide an insight on competitors, customers, and potential suppliers. We at GMI Research understands that the standard or on shelf company profiles provides little help when it comes to business decision making as it doesn’t cover the information required by the clients.

We have developed a range of company profiles solution to meet our client’s specific business requirements irrespective of their role and the industry they operate in. Our company profiles solutions fit into our client’s business requirements because it provides our client’s with a broader choice of profiles: 

https://www.gmiresearch.com/productservices/companyprofiles.html

Contact – Sarah Nash

U.S Office +1 860 881 2270
Europe Office +353 1 442 8820

Email: sales@gmiresearch.com

Global Dental adhesives Market Opportunities & Forecast (2018-2025)-GMI Research

Global Dental adhesives Market Opportunities & Forecast (2018-2025)-GMI Research

Global Dental adhesives Market by Product Type (i.e. Denture Adhesives, Pit, Restorative Adhesives, Fissure Sealants and Others); by Type/Form (i.e. Cream, Powder and Other); by End User (i.e. Hospitals, Dental Academic & Research Institutes, Dental Clinics and Others) and By Geography – Opportunities & Forecast, 2018-2025

Dental adhesives are widely used for esthetic dental restorations, repairing damaged tooth, etc. Dental adhesives are primarily resin monomers with adhesiveness, which helps in bonding to the natural substance of the teeth, i.e. enamel and dentin. The chemical composition of adhesives also includes curing initiators, inhibitors or stabilizers, solvents and, in some cases, inorganic fillers. Clinical application of dental adhesive can be classified into etch-and-rinse adhesives and self-etch adhesives. The advancement and utilization of dental adhesive materials has started to revolutionize various aspects adhesive dentistry.

Download Sample Brochure : https://tinyurl.com/y929dee4

Factors such as increasing patient pool of root and coronal caries, periodontitis, rising awareness towards oral health, increasing dental tourism have been fuelling the growth of the dental adhesive market in the forecasted period. Additionally, growing out of pocket expenditure coupled with increasing willingness of people to spend more on dental care to maintain dental aesthetics have spurred the growth of the dental adhesive market.

Moreover, the growing number of hospitals and clinics along with the surging demand for cosmetic dentistry and dental restorative procedures, especially in emerging economies like China and India are helping to boost the demand of dental adhesive even further during the forecasted period. However, alternate oral care methods and high treatment costs are primary impediments, restraining the growth of the dental adhesive market.

The notable players operating in the market include the likes of Dentsply Sirona Inc., 3M, Procter & Gamble Co. (P&G), Glaxosmithkline PLC (GSK), Danaher Corporation, Ivoclar Vivadent AG, GC Corporation, Stryker, Ultradent Products, Inc., Tokuyama Dental Corporation Inc., Voco GmbH among others. These global players have been focussing and investing heavily on R&D activities and strategic M&A activities to hold onto their leadership position in the market.

The global dental adhesives market has been segmented based on the product type/form, end user and key geographies. Based on the product type, the market comprises of denture adhesives, pit, restorative adhesives, and fissure sealants among others. The research report ‘global dental adhesives market’ provides in-depth analysis of global dental adhesives market based on product type, type/form, end user and major geographies for the forecast period from 2018 to 2025. The report highlights the major market drivers propelling a stupendous growth, and also indicated challenges faced by the market participants. Additionally, the research report provides the market size, based on which it forecasts  the growth prospect of the global dental adhesives market. The report also analyses the competitive landscape, major players, and the strategies they’d most likely adopt in 2018. The competitive landscape section of the report captures and highlights recent developments in the market.

Buy Now : https://www.gmiresearch.com/report/global-dental-adhesives-market.html

Key questions answered in this research report
1-    At what pace is dental adhesives market growing? What will be growth trend in future?
2-    What are the key drivers and challenges  in the current market? What will be their impact now, and the future?
3-    What are the regional revenue and forecast breakdowns? Which are the major regional revenue pockets for growth in the dental adhesives market?
4-    What are the various application areas and how they are poised to grow?

Market Segmentation
By Product Type

•    Denture Adhesives
•    Pit
•    Restorative Adhesives
•    Fissure Sealants
•    Others
By Type/Form
•    Cream
•    Powder
•    Other
By End User
•    Hospitals
•    Dental Academic & Research Institutes
•    Dental Clinics
•    Others
By Geography
•    North America 
As a part of customization
o    By Product Type
o    By Type/Form
o    By End User
o    US
o    Canada
o    Mexico
•    Europe
As a part of customization
o    By Product Type
o    By Type/Form
o    By End User
o    UK
o    Germany
o    Spain
o    Rest of Europe
•    Asia-Pacific
As a part of customization
o    By Product Type
o    By Type/Form
o    By End User
o    China
o    Australia
o    India
o    Rest of APAC
•    ROW
As a part of customization
o    By Product Type
o    By Type/Form
o    By End User
o    Brazil
o    South Africa
o    GCC countries

o    Rest of world (remaining countries of the LAMEA region)

Leading market players
•    Dentsply Sirona Inc.
•    3M
•    Procter & Gamble Co. (P&G)
•    Glaxosmithkline PLC (GSK)
•    Danaher Corporation
•    Ivoclar Vivadent AG
•    GC Corporation
•    Stryker
•    Ultradent Products, Inc.
•    Tokuyama Dental Corporation Inc.
•    Voco GmbH

*Other prominent players in the market which can be profiled as a part of customization:
•    ICPA Health
•    Bisco Dental Products, Inc.
•    Kuraray Noritake Dental Inc.
•    Yamahachi Dental Inc,

For more details, browse the Table of Contents: https://www.gmiresearch.com/report/global-dental-adhesives-market.html

Global Healthcare IoT Market exhibited a value of USD 66,102.3 million in 2017

Global Healthcare IoT Market exhibited a value of USD 66,102.3 million in 2017

Inpatient management in 2017 held the maximum share in the global healthcare iot market and is expected to witness a significant growth during the forecast period (2018-2025) owing to technological advantage and cost effectiveness – GMI Research

The global healthcare IoT market exhibited a value of USD 66,102.3 million in 2017, and is projected to reach USD 305,980.9 million by 2025, growing at a CAGR of 21.2% during 2018–2025.

Download Sample Brochure : https://tinyurl.com/ya6mhzwo

The key factors boosting the market growth are:
•    Increase in the prevalence of chronic diseases, such as heart failure, obesity, diabetes and hypertension that are boosting the demand for technologically advanced medical devices.
•    New tech generation connected medical devices enabling real-time patient monitoring; thereby, helping the medical professionals to swiftly respond to the patients’ needs.
•    The growing geriatric population, and the high unmet medical needs for home healthcare and long-term healthcare services.

Furthermore, increasing adoption of new generation medical devices at hospitals and clinics, growing incidence of chronic diseases, rising technological advancement and spending on healthcare facilities across the globe have led to the burgeoning market growth of healthcare IoT market.

Medical device product type is expected to dominate the global healthcare IoT market during the forecast period. In 2017, more than half of the market share was held by the medical device. However, systems and software product type is expected to witness the fastest growth rate in the coming years on account of growing adoption among healthcare professionals and patients due to extreme advancement in technology.

The healthcare practitioners are using technology platforms to serve the growing hospital and patient needs. Additionally, numerous routine activities such as patient data recording, storage of data and data analysis have been streamlined using software’s and cloud storage systems, leading to significant reduction in healthcare operational costs and errors. The penetration of technologically advanced connected medical devices, introduction of smart phones, and use of software automation, to enable faster and accurate patient testing, and provide better accuracy, ease of usage & portability is expected to serve Internet of Things in healthcare market as high-impact rendering driver over the forecast period.

“Market leaders and key players consistently investing in research & development activities to keep their leadership in the competitive healthcare IoT market. Further, the healthcare IoT market is witnessing significant growth in Asia-Pacific due to growing number of chronic disease population in the region, specifically, in the countries, such as China and India.”
—-GMI Research

In 2017, North America held the largest share in the market on the back of increased adoption of technology, high volume of hospitals & clinics procedures and need of accurate diagnosis. In addition, there has been a rise in incidence of chronic disease and; hence, increased government and private funding on healthcare infrastructure. Europe is a third fastest growing region for healthcare IoT market and is predicted to grow at a moderate rate during the forecast period.

Key takeaways:
•    In 2017, the hospitals and clinics held most of the market share.
•    Cisco Ltd, Medtronic Plc and Phillips, and IBM are the leading players holding approximately around one third of the market share.
•    The systems and software product type is anticipated to grow at the highest rate during the forecast period from 2018 to 2025.
•    North America region occupied the maximum revenue share in the global healthcare iot market in 2017.

Some of the key players operating in the global healthcare IoT market include Cisco Systems, Inc, Koninklijke Philips N.V, IBM Corporation, Stanley Healthcare, Medtronic plc, Qualcomm Life, Inc, Honeywell Care Solution, Microsoft Corporation, GE Healthcare & Apple Inc and others.

The global healthcare IoT market has been segmented on the basis of product type, application type, end user and key geographies. Based on product type, the global healthcare IoT market comprises of medical devices, systems and software, and services. The application type includes clinical and work flow management, telemedicine, inpatient management and others. The end user segment includes, clinical research organizations, diagnostic laboratories, hospitals & clinics and others.

The research report on healthcare IoT market provides in-depth analysis of the global healthcare IoT market, based on: product type, application type, end user and major geographies for the forecast period from 2018 to 2025. The report highlights the major market drivers propelling the growth as well as challenges faced by the market participants. The research report also provides market size and forecast for healthcare IoT market. The report also analyses the competitive landscape, major players and their strategies in 2018. The competitive landscape section of the report captures and highlights the recent developments in the market.

For more details, browse the Table of Contents: https://www.gmiresearch.com/report/global-healthcare-iot-market-2108-2025-share-nih-trends-medical-device-software-application.html


Contact

Sarah Nash
Level 1, The Chase Carmanhall Road,
Sandyford Industrial Estate,
Dublin D18 Y3X2, Ireland
U.S Office +1 860 881 2270
Europe Office +353 1 442 8820
Global Hybrid Operating Room Market exhibited a value of 704.3 million in 2017

Global Hybrid Operating Room Market exhibited a value of 704.3 million in 2017

Growing patient preference for affordable & effective surgical treatments is expected to positively influence the growth of global hybrid operating room market during the forecast period

The global hybrid operating room market exhibited a value of 704.3 million in 2017, and is expected to reach USD 1,572.0 million by 2025, growing at a CAGR of 10.8% during 2018–2025.

Download Sample Brochure : https://tinyurl.com/y7yeo32x

The key factors boosting the market growth are: 
•    Growing minimally invasive surgeries and technological advancement in robot assisted surgeries
•    Rising government & private investments for healthcare facilities infrastructure
•    Increasing awareness and rising patient emphasis on timely and effective disease management

Hybrid operating room is gaining traction in large, urban healthcare facilities due to increasing preference for minimally invasive surgeries, and the massive investments for the development of novel technologies that can help in improving healthcare systems for patients.

Some of the other factors affecting the market growth are technological advancements in the field of robot-assisted surgeries, improved patient outcomes with less invasive procedures, fewer per-procedural complications. Moreover, shorter ICU stays in the hospital directly linked to reduced cost of the procedure which is likely to drive demand for the hybrid operating room market, globally.

Intraoperative diagnostic devices segment holds the largest revenue share in 2017 and is expected to exhibit significant revenue share during the forecast period owing to increasing installation of hybrid ORs across major economies, significant installation costs associated with diagnostic imaging products, ongoing integration and automation of operating room workflows and continuous technological advancements in the field of diagnostic imaging.

Hospital segment holds the largest market share in the 2017 and is predicted to grow at a CAGR 11.4% during the forecast period owing to rising patient emphasis on timely and effective disease management and increasing number of hospitals and surgical centers in developing countries. Also, significant healthcare spending and increasing government & private investments for healthcare facilities infrastructure are expected to lay down the best path for the market to grow

“Strategic collaboration among manufacturers, healthcare providers, accrediting organizations, professional societies, and government agencies may help to design, approve and construct hybrid operating room throughout the world, hence, such collaboration will benefit all stakeholders.”
—-GMI Research

Based on geography, North America held the largest share in the market in 2017 due to significant investments by hospitals to upgrade their operating rooms, increasing number of surgical procedures and ambulatory surgery centers in the region. In addition, presence of advanced medical and healthcare infrastructure is expected to boost the market growth during the forecast period. Asia-Pacific is projected to grow at significant growth rate during 2018-2025 due to rising patient preference for affordable & effective surgical treatments, advancements in operating room technology, rising disposable income, etc.

Key takeaways:
•    The intraoperative diagnostic devices segment is expected to grow at an estimated CAGR of 11.6% during the forecast period,
•    Leading players in the hybrid operating room market, such as General Electric Company, F Koninklijke Philips N.V., and Siemens AG are more focussed strategic collaboration to expand their business.
•    The rapid rise in the volume of minimally invasive surgery has increased demand for hybrid operating room across the globe
•    North America has been a leading region in the installation of hybrid operating suites and construction of hybrid operating rooms

Some of the key players operating in the global hybrid operating room market, include Siemens AG
Toshiba Medicals Systems Corporation, Stryker Corporation, General Electric Company, IMRIS Inc., Koninklijke Philips N.V., Eschmann Holdings Ltd., Getinge AB, TRUMPF Medical Systems, Inc., Skytron LLC., among others.

The global hybrid operating room market has been segmented based on product type, end use and key geographies. Based on the product type which include surgical imaging displays, communication system, intraoperative diagnostic devices, operating tables, surgical booms and others.
Based on end use, the market has been segmented into hospitals, ambulatory surgical centres and others

The research report “global hybrid operating room market” provides in-depth analysis of hybrid operating room across the globe, based on product type, end use and major geographies for the forecast period from 2018 to 2025. The report highlights the major market drivers propelling the growth as well as challenges faced by the market participants. The research report also provides market size and forecast for hybrid operating room market. The report also analyses the competitive landscape, major players and their strategies in 2018. The competitive landscape section of the report captures and highlights the recent developments in the market.

For more details, browse the Table of Contents: https://www.gmiresearch.com/report/global-hybrid-operating-room-market-share-trends-forecasts-insights-end-user.html


Contact

Sarah Nash
Level 1, The Chase Carmanhall Road,
Sandyford Industrial Estate,
Dublin D18 Y3X2, Ireland
U.S Office +1 860 881 2270
Europe Office +353 1 442 8820